Organization
Oxford Vacmedix
1 clinical trial
6 abstracts
Clinical trial
A Phase 1, Multicentre, Open-label, Nonrandomised, First-in-human Study of OVM-200 as a Therapeutic Vaccine in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Ovarian Cancer, and Prostate CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Abstract
Evaluating the diagnostic performance of 18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial.Org: Department of Neurosurgery, Prince of Wales Hospital, Department of Radiation Oncology, Baptist Health South Florida, Perelman School of Medicine, Department of Radiology,
Abstract
Integrating polygenic risk scores into clinical breast cancer models: Influence on prediction in diverse cohorts.Org: Allelica Inc, Rome, Nykode Therapeutics, Hartford Healthcare Cancer Institute, Italy,
Abstract
Pirtobrutinib in covalent BTK-inhibitor (cBTKi) pre-treated mantle cell lymphoma (MCL): Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment.Org: Medical College of Wisconsin, Milwaukee, WI, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland, IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica,
Abstract
ADALIMUMAB IS EFFECTIVE AND WELL-TOLERATED IN TREATING ANKYLOSING SPONDYLITIS (AS) IN REAL-LIFE CLINICAL PRACTICE: PRELIMINARY RESULTS OF THE RHAPSODY TRIALOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Charité University Hospital, Berlin Heals, Germany, CHU de Henri-Mondor,
Abstract
ASSESSMENT: HOW TO PERSONALIZE SECONDARY FRACTURE PREVENTION?Org: University of Oxford, NDORMS, Oxford Vacmedix,
Abstract
Belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: effect on biomarkersOrg: University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, UK University Hospital Gasthuisberg, Leuven Cancer Institute, Belgium Botnar Research Centre,